Search results
Enrolling in Medicare | UCNet
UC Newsroom· 6 days agoIf you’re like most people, when you turn 65 you will become eligible to enroll in Medicare, the federal program to provide older adults and those with disabilities or permanent kidney failure ...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 1 day agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoKey Takeaways
Commentary: Minority Health Month is a time to raise awareness about health disparities
Daily Press· 3 days agoApril is Minority Health Month, a time to acknowledge and raise awareness about health disparities...
JD Supra: Cozen Currents: Casting Trump II: The Sequel
JD Supra· 4 days agoA second Trump administration would likely include both familiar faces from his first term and newcomers, but a lack of institutional guardrails means that former President Trump’s personnel ...
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers
The National Law Review· 5 days agoThe Office of Inspector General (OIG) recently issued a new favorable advisory opinion regarding...
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 1 day agoFree Report) is predicted by Wall Street analysts to post quarterly earnings of $6.17 per share, reflecting an increase of 14.1% compared to the same period last year. Analysts expect 'Medical Care Ratio - Cigna Healthcare' to come in at 81.9%.
Mirae Asset Global Investments Co. Ltd. Has $630,000 Stake in eHealth, Inc. (NASDAQ:EHTH)
ETF DAILY NEWS· 4 days agoMirae Asset Global Investments Co. Ltd. lifted its stake in shares of eHealth, Inc. (NASDAQ:EHTH – Free Report) by 101.8% in the 4th quarter, according to the company in its most recent filing ...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 4 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.
